Catheter Precision EV/FCF

Mitä Catheter Precision tekee? Catheter Precision Inc, trading under the ticker VTAK, is a US-based health care company headquartered in Fort Mill. The company has 14 employees and went public via an IPO on September 27, 2018. Its website is https://www.ramed.com/. Catheter Precision Inc operates within the health care sector, focusing on medical technology solutions. The company's product portfolio includes the Amigo remote catheter system, which features an open architecture design allowing for use in additional catheter procedures. It also offers the VIVO non-invasive three-dimensional imaging system, designed to help physicians identify the origin of arrhythmias before procedures, thereby streamlining workflow and reducing procedure time. Additionally, the company develops the LockeT suture retention device. Catheter Precision Inc is engaged in developing technologies for electrophysiology procedures, collaborating with physicians to advance its product offerings. The company aims to improve treatment outcomes for patients with cardiac arrhythmias through its medical technologies. Its focus is on providing solutions that enhance the efficiency and effectiveness of cardiac arrhythmia treatments in clinical settings. The company's products are intended for use by hospitals, physicians, and patients seeking improved care for cardiac conditions. The firm's operations are centered on innovation in electrophysiology, with an emphasis on creating tools that support better patient outcomes and more efficient medical procedures. Catheter Precision on yksi Eurpooliin suosituimmista yhtiöistä.